Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model
Trem2 verschlimmert ischämische Hirnschädigung über Gpnmb in einem photothrombotischen Schlaganfallmodell
Proceedings of the National Academy of Sciences · 21.04.2026 · 123 (16)
DOI: 10.1073/pnas.2523148123 ↗Auf einen Blick
In einem photothrombotischen Mausmodell verschlechterte Trem2 die ischämische Hirnschädigung. Trem2-Deletion verminderte Infarkt, Entzündung und neurologische Defizite; sTrem2 und sGpnmb verschlechterten die Befunde.
Fragestellung
Welchen Einfluss hat Trem2 auf die ischämische Hirnschädigung im photothrombotischen Schlaganfallmodell?
Methode
Photothrombotisches Schlaganfallmodell bei Maus; Analyse von Trem2-Depletion, intrazerebraler sTrem2- und sGpnmb-Gabe sowie integrierte Maus-Mensch-Transkriptomik.
Ergebnisse
Trem2-Depletion reduzierte Infarktvolumen, proinflammatorische Zytokine und neuronalen Schaden und milderte motorische sowie neurologische Beeinträchtigung. sTrem2 und sGpnmb verstärkten Entzündung und neuronalen Verlust.
Schlussfolgerung der Autor:innen
Die Autor:innen beschreiben Trem2 als schädlichen Faktor bei ischämischem Schlaganfall und den Trem2–Gpnmb-Weg als potenzielles therapeutisches Ziel zur Abschwächung postischämischer Neuroinflammation.
Kernaussagen
- Trem2-Depletion war mit weniger Infarkt und weniger Entzündung verbunden.
- sTrem2 und sGpnmb verschlechterten neuronale Schädigung und Defizite.
- Trem2–Gpnmb könnte ein therapeutisches Ziel sein.
Deutsche Zusammenfassung: KI-gestützt aus dem Original-Abstract erstellt; alle Zahlen wurden automatisch mit dem Original abgeglichen. Maßgeblich ist der Original-Abstract.
Kurz gefasst
Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 14.04.2026. Verfasst von Xuezhen Chen und 12 weiteren Autor:innen. Beteiligte Einrichtung: The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China. Hauptthemen laut MEDLINE: Membrane Glycoproteins, Receptors, Immunologic, Brain Ischemia, Thrombotic Stroke. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 88 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases, Shenzhen Science and Technology Program.
Themen: Schlaganfall
Abstract (Originalsprache)
Ischemic stroke is a major public health challenge, with microglia-mediated neuroinflammation exerting both protective and detrimental effects on neuronal survival. The Triggering receptor expressed on myeloid cells 2 (Trem2), predominantly expressed by microglia, has been reported to confer neuroprotection in the middle cerebral artery occlusion (MCAO) model. Paradoxically, in patients, elevated plasma soluble Trem2 (sTrem2) levels correlate with increased risk and poor outcomes. To test the impact of Trem2 function in the context of stroke, we utilized the photothrombotic stroke model which elicited strong Trem2 upregulation, a clinical feature which is not mimicked in MCAO models. Trem2 depletion reduced infarction volume, suppressed proinflammatory cytokine production, preserved neuronal survival, and lessened motor and neurological impairment. Conversely, intracerebral administration of sTrem2 exacerbated neuronal loss, amplified inflammation, and worsened neurological deficits. Integrated mouse-human transcriptomic analyses identified glycoprotein nonmetastatic B (Gpnmb) as a conserved downstream effector of Trem2. Soluble Gpnmb (sGpnmb) administration abolished the protective effects of Trem2 depletion, promoting microglial activation, lipid accumulation, and neuronal damage. Additionally, plasma sTrem2 and sGpnmb levels were elevated in stroke patients, positively correlated, and may serve as biomarkers of poor prognosis. These findings uncover a detrimental role for Trem2 in ischemic stroke, provide mechanistic insight into the link between sTrem2 and poor clinical outcomes, and identify the Trem2–Gpnmb axis as a potential therapeutic target to mitigate poststroke neuroinflammation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Brain Cognition and Brain Disease Institute, Shenzhen Institutes of Advanced Technology, Chinese Academy of Sciences, Shenzhen 518055, China.
- Bio-X international institute, Faculty of Life and Health Sciences, Shenzhen University of Advanced Technology, Shenzhen 518107, China.
- Ministry of Education Key Laboratory of Gene Function and Regulation, Guangdong Province Key Laboratory of Pharmaceutical Functional Genes, State Key Laboratory of Biocontrol, School of Life Sciences, Sun Yat-sen Univer…
- Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases, Shenzhen 518055, China.
- University of Chinese Academy of Sciences, Beijing 100049, China.
- Shenzhen Hospital of Shanghai University of Traditional Chinese Medicine, Shenzhen 518001, China.
ORCID-Profile: Sagun Tiwari, Fan Zeng, Xinzhou Zhu
Förderung
- National Natural Science Foundation of China
- Shenzhen Key Laboratory of Neuroimmunomodulation for Neurological Diseases
- Shenzhen Science and Technology Program
- Shenzhen Science and Technology Program-The Excellent Youth Scholars
- Chinese Academy of Sciences Global Common Challenges Program
- Shenzhen Medical Academy of Research and Translation
Zitieren
APA
Chen, X., Li, K., Liu, S., Zhao, J., Tiwari, S., Zeng, F., Zhao, Y., Zhang, P., Tang, H., Zhao, H., Kettenmann, H., Xiang, X., & Zhu, X. (2026). Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model. Proceedings of the National Academy of Sciences, 123(16). https://doi.org/10.1073/pnas.2523148123
Vancouver
Chen X, Li K, Liu S, Zhao J, Tiwari S, Zeng F, et al. Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model. Proceedings of the National Academy of Sciences. 2026;123(16). doi:10.1073/pnas.2523148123
BibTeX
@article{Chen2026,
author = {Chen, Xuezhen and Li, Kunyu and Liu, Siyu and Zhao, Junyi and Tiwari, Sagun and Zeng, Fan and Zhao, Yue and Zhang, Pingping and Tang, Han and Zhao, Hong and Kettenmann, Helmut and Xiang, Xianyuan and Zhu, Xinzhou},
title = {Trem2 exacerbates ischemic brain injury through Gpnmb in a photothrombotic stroke model},
journal = {Proceedings of the National Academy of Sciences},
year = {2026},
volume = {123},
number = {16},
doi = {10.1073/pnas.2523148123}
}
EUVIMED